Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Consider contacting your GP if you experience: Persistent or significant decrease in libido that affects your quality of life or relationships Changes in sexual function accompanied by other concerning symptoms (mood changes, fatigue, pain) Erectile dysfunction or other physical difficulties with sexual activity Relationship difficulties related to changes in intimacy Symptoms suggesting hormonal imbalance (irregular periods, hot flushes, changes in body hair) Seek immediate medical attention if you experience: Severe, persistent abdominal pain, especially if radiating to the back, with or without vomiting (possible pancreatitis) Right upper abdominal pain, jaundice (yellowing of skin/eyes), or fever (possible gallbladder disease) Your healthcare provider can conduct a comprehensive assessment to identify potential contributing factors: Medication review : Evaluating all current medications, as some drugs (antidepressants, blood pressure medications, hormonal contraceptives) are known to affect libido Physical examination : Checking for signs of hormonal imbalance or other medical conditions Blood tests : Assessing hormone levels (testosterone, thyroid function), vitamin deficiencies, or metabolic markers if clinically indicated Mental health evaluation : Screening for depression, anxiety, or stress that may impact sexual function For erectile dysfunction, your GP may assess cardiovascular risk factors and consider referral if symptoms persist or if low testosterone is suspected
Very true the question that needs to be asked is how to give HRT
Potential Health Risks While occasional moderate drinking may be acceptable for some people on GLP-1 medications, there are some serious health considerations to be aware of: Pancreatitis Risk Both long-term or heavy alcohol use and GLP-1 medications like Ozempic have been associated with pancreatitis (inflammation of the pancreas)
Methods Using a subset of Truveta Data, we found a population of adolescent patients (aged 12-17 years old) who had a recorded body mass index (BMI) on the same day as an outpatient visit between January 1, 2021 and March 31, 2025
The short answer is that general subcutaneous injection education usually points to the abdomen, outer thigh, and upper arm, but that does not make injectable GHK-Cu an approved medication or a safe self-treatment
